Acta Pharmaceutica Sinica B
|
2025, 15(3): 1721-1721
Author correction to “Up-regulation of glyclipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication” [Acta Pharm Sin B 9 (2019) 769–781]
Full
- aInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
- bDepartment of Liver Diseases, The Second Hospital of Nanjing, Southeast University, Nanjing 210003, China
- cState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
About Author:
†
These authors made equal contributions to this work.
doi: 10.1016/j.apsb.2024.12.001
Menghao Huang, Hu Li, Rong Xue, Jianrui Li, Lihua Wang, Junjun Cheng, Zhouyi Wu, Wenjing Li, Jinhua Chen, Xiaoqin Lv, Qiang Li, Pei Lan, Limin Zhao, Yongfeng Yang, Zonggen Peng, Jiandong Jiang.
Author correction to “Up-regulation of glyclipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication” [Acta Pharm Sin B 9 (2019) 769–781][J].
Acta Pharmaceutica Sinica B,
2025
, 15
(3)
: 1721
-1721
.
DOI: 10.1016/j.apsb.2024.12.001
The authors regret that a correction was made in the Materials and Methods section concerning the incomplete supplier information. The antibody for HCV NS5A (pab24633) was from Abnova (Taipei, Taiwan, China). This correction has no influence on the readers' understanding of the article.
The authors apologize for any inconvenience caused to the journal and its readers.